Description of the Immune Response to Yellow Fever Vaccination

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorInstitut Pasteur

About this trial

Vaccine protection depends on a specific adaptive immune memory. However, a little-explored aspect of certain live vaccines may provide beneficial, non-specific protection against infections or pathogens other than the one from which the vaccine is derived. This is the concept of innate immune memory or " trained immunity", which differs from adaptive memory in its non-specificity. Innate immune memory is triggered by exposure to immunostimulants, and offers protection against unrelated pathogenic threats for several months or even years.

The project aims to carry out an exploratory study to observe, in the context of current practice, the immune response obtained after a subunit and a live attenuated vaccine

Eligibility criteria

Qualifiers

Age between 18 and 65

Referred for immunisation against yellow fever and typhoid

Yellow fever

Typhoïd

Disqualifiers

Anyone with a contraindication to yellow fever and/or typhoid vaccination.

Any person who has been vaccinated against yellow fever and/or typhoid.

Anyone who has lived in an endemic area (≥ 1 year) and/or has a history of Typhoid.

Anyone who is unable to attend the visit 1-month after the typhoid vaccine injection.

Trial design

Treatments tested in this trial

  • blood samples collection

Treatment groups

38 Participants
are divided into 1 treatment group

Sponsors and collaborators